Cardinal Health, Inc. (CAH)
- Previous Close
98.84 - Open
98.69 - Bid 99.10 x 900
- Ask 99.14 x 800
- Day's Range
98.04 - 99.42 - 52 Week Range
85.12 - 116.04 - Volume
371,346 - Avg. Volume
2,040,374 - Market Cap (intraday)
24.096B - Beta (5Y Monthly) 0.65
- PE Ratio (TTM)
43.77 - EPS (TTM)
2.26 - Earnings Date Aug 13, 2024 - Aug 19, 2024
- Forward Dividend & Yield 2.02 (2.05%)
- Ex-Dividend Date Jul 1, 2024
- 1y Target Est
113.74
Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.
www.cardinalhealth.comRecent News: CAH
Performance Overview: CAH
Trailing total returns as of 6/11/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CAH
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CAH
Valuation Measures
Market Cap
24.07B
Enterprise Value
26.21B
Trailing P/E
43.73
Forward P/E
13.12
PEG Ratio (5yr expected)
0.30
Price/Sales (ttm)
0.11
Price/Book (mrq)
--
Enterprise Value/Revenue
0.12
Enterprise Value/EBITDA
15.45
Financial Highlights
Profitability and Income Statement
Profit Margin
0.25%
Return on Assets (ttm)
2.92%
Return on Equity (ttm)
--
Revenue (ttm)
220.57B
Net Income Avi to Common (ttm)
552M
Diluted EPS (ttm)
2.26
Balance Sheet and Cash Flow
Total Cash (mrq)
3.72B
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
1.67B
Research Analysis: CAH
Company Insights: CAH
CAH does not have Company Insights
Research Reports: CAH
Argus Quick Note: Weekly Stock List for 05/28/2024: Activist Stocks
Vickers Stock Research, a subsidiary of Argus Research Group, tracks and analyzes insider trading and institutional stock ownership trends. Form 13-Fs, which institutions must file to report their holdings, are due 45 days after the end of calendar quarters, and have now come in from 1Q24. We like to review the 13Fs of the major activist investors, including Carl Icahn, Trian Fund Management, Jana Partners, and ValueAct Holdings, among others, to determine their core holdings and new purchases. Activist investing has evolved in recent years and is now less about generating a short-term return on an underpriced stock and more about achieving long-term returns through an active management/investor partnership. Activists have made progress in the past year with high-profile investments into blue-chip companies such as Fedex and Union Pacific. According to Vickers, here are recent new purchases and key holdings of activist investors and other high-profile money managers such as Warren Buffet of Berkshire Hathaway and Ken Griffin of Citadel Advisors LLC.
Recent weakness provides buying opportunity
Cardinal is one of the nation's largest pharmaceutical and medical distribution companies. Its Pharmaceutical segment distributes a wide range of branded and generic drugs, specialty drugs, and over-the-counter products. The Medical segment distributes medical, surgical, and laboratory products to hospitals and other healthcare providers. The company has about 44,000 employees. The shares are a component of the S&P 500.
RatingPrice TargetThe technical scorecard for stocks remains bullish, as indices at new all-time
The technical scorecard for stocks remains bullish, as indices at new all-time highs (and others missing by only a few points) are actually lagging advance/decline lines that have led price to new highs. Historically, when market breadth leads price, it has been bullish when looking out six to 12 months.
Cardinal Health Earnings: Sales Growth Starts to Slow but Margin Comes Through
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and McKesson, the three comprise well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
RatingPrice Target